Integrated Proteins last traded at ₹13.05 (2026-10-13). Over the past month the stock moved -11.8%, three months the stock moved -90.1%, year the stock moved -64.0%. Its closing range over 52 weeks is ₹12.80 – ₹163.15, with the latest close 92.0% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1992, Integrated Proteins Ltd is in the business of trading in various oil seeds and agri commodities.[1]
Business Overview:[1] IPL is engaged in the business of manufacturing, trading, and processing various oilseeds. There was an operational shift in the business as: a) The company ceased operations in the solvent extraction of oilseeds. b) In FY24, the company explored one of its main objectives and commenced trading in agri commodities.
In the latest quarter (Jun 2026), Integrated Proteins reported sales of ₹10.55 crore and net profit of ₹0.36 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 10.55 | 0.46 | 4.36 | 0.36 | 0.19 |
| Mar 2026 | 5.69 | 0.22 | 3.87 | 0.19 | 0.10 |
| Dec 2025 | 0.00 | -0.02 | – | -0.02 | -0.01 |
| Sep 2025 | 4.20 | 0.09 | 2.14 | 0.05 | 0.03 |
| Jun 2025 | 0.00 | -0.05 | – | 0.00 | 0.00 |
| Mar 2025 | 21.49 | 0.23 | 1.07 | 0.21 | 0.66 |
| Dec 2024 | 0.01 | -0.04 | -400.00 | 0.07 | 0.22 |
| Sep 2024 | 0.00 | -0.07 | – | -0.03 | -0.08 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | +8854.2% | – | – | -100.0% | -73.5% | – |
| Operating profit growth | – | – | – | – | – | – | -4.3% | – |
| Net profit growth | -400.0% | -12.5% | +950.0% | – | – | -128.6% | -9.5% | – |
| EPS growth | -366.7% | +0.0% | +1220.0% | – | – | -104.5% | -84.8% | – |
| OPM % | – | -400.0% | 1.1% | – | 2.1% | – | 3.9% | 4.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Integrated Proteins reported sales of ₹9.94 crore (-53.8%) and net profit of ₹0.23 crore (-8.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 9.94 | 0.27 | 2.72 | 0.23 | 0.12 |
| Mar 2025 | 21.50 | 0.09 | 0.42 | 0.25 | 0.68 |
| Mar 2024 | 0.24 | -0.12 | -50.00 | 0.09 | 0.24 |
| Mar 2023 | 0.17 | -0.09 | -52.94 | 0.03 | 0.08 |
| Mar 2022 | 0.00 | -0.08 | – | 0.04 | 0.11 |
| Mar 2021 | 0.00 | -0.10 | – | 0.02 | 0.05 |
| Mar 2020 | 0.00 | -0.11 | – | 0.01 | 0.03 |
| Mar 2019 | 0.00 | -0.14 | – | 0.02 | 0.05 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | +41.2% | +8858.3% | -53.8% |
| Operating profit growth | – | – | – | – | – | – | – | +200.0% |
| Net profit growth | +100.0% | -50.0% | +100.0% | +100.0% | -25.0% | +200.0% | +177.8% | -8.0% |
| EPS growth | +66.7% | -40.0% | +66.7% | +120.0% | -27.3% | +200.0% | +183.3% | -82.4% |
| OPM % | – | – | – | – | -52.9% | -50.0% | 0.4% | 2.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Integrated Proteins.
Get Free AI Stock Analysis FREE →Integrated Proteins re-designates Hiren Shah as CMD for five-year term - scanx.trade
Integrated Proteins seeks reclassification of promoters to public - scanx.trade
Broad-Based Technical Strength Lifts Integrated Proteins Ltd to 52-Week High of Rs 139.65
Integrated Proteins Ltd Hits All-Time High of Rs 139.65 as Momentum Builds Across Timeframes
Integrated Proteins standalone net profit rises 9.52% in the March 2026 quarter - Business Standard
Integrated Proteins shares were last quoted at ₹13.05 (-4.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Integrated Proteins has a price-to-earnings (P/E) ratio of 443.33 and a price-to-book (P/B) ratio of 12.09. The industry P/E is 36.54.
The 52-week high of Integrated Proteins is ₹16.32 and the 52-week low is ₹2.07.
The market capitalisation of Integrated Proteins is about ₹248.89 crore.
In the latest quarter (Jun 2026), Integrated Proteins reported sales of ₹10.55 crore and net profit of ₹0.36 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Integrated Proteins has a 3-year ROE of 1.00%, 3-year profit growth of 97.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 2.24% of Integrated Proteins.
Integrated Proteins belongs to the Vegetable Oils & Products sector.
All Vegetable Oils & Products stocks · Browse all stocks A–Z